[Typical risks in the therapy of obliterating vascular diseases].
D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D003327:Coronary Disease / Q000628:therapy*; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D008297:Male; D012306:Risk; D012907:Smoking; D013923:Thromboembolism / Q000628:therapy*; D013997:Time Factors
D000925:Anticoagulants
Typische Risiken bei der Therapie obliterierender Gefässkrankheiten.